Abstract

Positron emission tomography (PET)/computed tomography has recently been finding broader application for the diagnosis, treatment and therapy assessment of malignant disease. Accurate definition of the tumor border is extremely important for the success of localized tumor therapies. PET promises to provide the metabolically active tumor volume and, at present, it is used for target definition in a variety of tumors. This process is, however, subject to uncertainties of different origin. Resolving these uncertainties is challenging, since validating PET images and segmentation contours against tumor pathology is experimentally difficult. In addition to accurate lesion contouring, this challenges validation of PET tracers and investigations of tumor functional heterogeneity. In this paper, we briefly review the present studies providing PET image data sets with pathology validation. We focus on the specimen handling techniques aimed at achieving higher geometrical accuracy of the pathology-derived “ground truth”. We also summarize the main findings obtained for the PET segmentation techniques which have been tested with the help of these data sets. Finally, we provide a critical summary of the current state of the art in pathological validation of PET images and briefly discuss future possibilities in this direction.

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.